This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Here’s a copy of the recent talk on Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition. It’s based on the book Make Better Decisions, which distills insights…. The post Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition appeared first on DrugPatentWatch - Make Better Decisions.
Happy 2020! There is something about a new decade that brings a sharper focus on the future. At Pharma Packaging Solutions, we are celebrating 25 years of pharmaceutical packaging experience and now we look forward to the next 25 years. Our 1995 facility addition in East Tennessee and focus on pharmaceutical packaging has been a journey through myriad technical challenges, a learning curve through regulatory change, and a pleasure through many customer success stories.
YS is a 79-year-old female with a medical history of osteoarthritis, insomnia, CVD, GERD, constipation, dementia, and falls. Her current medication list includes donepezil, Senna-S, lisinopril, zolpidem, amitriptyline, baby aspirin, acetaminophen, and omeprazole. Over the last three months, she has had a total of 7 falls and one that resulted in a fractured wrist.
I recently received a text from a friend about the use of oral semaglutide in a patient with diabetes. It is definitely exciting to have more options for patients, even though we know there will inevitably be insurance coverage hurdles to jump through. Here are a few things that you should remember about this first […]. The post Oral Semaglutide Clinical Pearls appeared first on Med Ed 101.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Oftentimes there are numerous agents within a class of medication. Ropinirole (Requip) and pramipexole (Mirapex) is an example of this. When comparing ropinirole and pramipexole, there are clinical differences that might alter which one you choose. Comparing Ropinirole and Pramipexole Pharmacokinetics The most obvious difference when comparing ropinirole and pramipexole involves pharmacokinetic differences.
FDA Approval The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m seeing used in clinical practice, this is a great thing for overall healthcare and drug costs. Here’s the FDA’s statement. Because of this switch to generic apixaban availability as well as the recent 2019 atrial fibrillation […].
40
40
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
FDA Approval The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m seeing used in clinical practice, this is a great thing for overall healthcare and drug costs. Here’s the FDA’s statement. Because of this switch to generic apixaban availability as well as the recent 2019 atrial fibrillation […].
In this case study, we discuss a situation where a drug causes a higher pH in the stomach. The elevated pH from an antacid can impact the absorption of other drugs. A 44-year-old female presents to the clinic with Strep throat. Her current medications include celecoxib for arthritis pain and ranitidine 150 mg BID for […]. The post High pH in the Stomach?
Diclofenac gel can be a beneficial tool in the management of localized osteoarthritis pain. There are many situations where acetaminophen is not effective and oral NSAIDs are intolerable or inappropriate. This is a type of situation where diclofenac gel may be appropriate to consider. Here are a few mistakes and clinical pearls that you should […].
Much like the BCPS exam, the BCACP (Board Certified Ambulatory Care Pharmacist) exam is undergoing changes for the fall of 2020. (If you are looking for a breakdown of the BCPS 2020 Changes, find them here.) BCACP exam changes likely include a significantly greater emphasis on ambulatory care and clinical topics. This is a welcomed […]. The post BCACP Exam Changes for Fall of 2020 appeared first on Med Ed 101.
2020 Pharmacist Provider Status is being considered by the Trump administration. This is a good thing for the profession and more importantly, a good thing for patients. There were a couple of quotes from CMS Administrator Seema Verma with regards to provider status that really demonstrates that it could be on the way. Here are […]. The post 2020 Pharmacist Provider Status.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content